2025
SJR Q2
JCR Q2 · 4
30 matched articles
SCIE
Journal detail
Expert Review of Clinical Immunology
- Publisher
- Taylor and Francis Ltd.
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1744666X17448409
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,198
- Quartile Q2
- H-Index 85
- Cites/doc 4,07
- Docs (3y) 367
- Cites (3y) 1.543
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4
- 5Y JIF 4,1
- JCI 0,5
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 1,198 | 4 | 4,1 | 0,5 | Q3 | 85 |
| 2024 | Q2 | Q2 | 1,125 | 3,7 | 4,1 | 0,5 | Q3 | 78 |
| 2023 | Q2 | Q2 | 1,208 | 3,9 | 4,7 | 0,51 | Q3 | 78 |
| 2022 | Q2 | Q2 | 1,136 | 4,4 | 4,8 | 0,51 | Q3 | 78 |
| 2021 | Q2 | Q2 | 1,152 | 5,1 | 4,9 | 0,51 | Q3 | 78 |
| 2020 | Q2 | Q2 | 1,235 | 4,5 | 4,2 | 0,57 | Q3 | 78 |
| 2019 | Q2 | Q2 | 1,031 | 3,8 | 3,4 | 0,53 | Q4 | 78 |
| 2018 | — | Q2 | — | 3,9 | 3,3 | 0,55 | Q3 | — |
| 2017 | Q2 | Q2 | 1,097 | 3,4 | 3,2 | 0,5 | Q4 | 78 |
| 2016 | Q2 | Q2 | 1,026 | 3,3 | 2,9 | — | — | 78 |
| 2015 | Q2 | Q3 | 0,862 | 2,6 | 2,6 | — | — | 78 |
| 2014 | Q2 | Q3 | 0,824 | 2,5 | 2,4 | — | — | 78 |
| 2013 | Q2 | Q2 | 1,032 | 3,3 | 2,4 | — | — | 78 |
| 2012 | Q2 | Q3 | 0,793 | 2,9 | — | — | — | 78 |
| 2011 | Q3 | Q3 | 0,621 | 2,1 | — | — | — | 78 |
| 2010 | Q4 | Q4 | 0,209 | 0,6 | — | — | — | 78 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q2 | Q3 | 75/183 |
| 2024 | IMMUNOLOGY | SCIE | Q2 | Q3 | 75/183 |
| 2023 | IMMUNOLOGY | SCIE | Q2 | Q3 | 79/181 |
| 2022 | IMMUNOLOGY | SCIE | Q2 | Q3 | 77/161 |
| 2021 | IMMUNOLOGY | SCIE | Q2 | Q3 | 72/162 |
| 2020 | IMMUNOLOGY | SCIE | Q2 | Q3 | 72/162 |
| 2019 | IMMUNOLOGY | SCIE | Q2 | Q4 | 64/159 |
| 2018 | IMMUNOLOGY | SCIE | Q2 | Q3 | 60/158 |
| 2017 | IMMUNOLOGY | SCIE | Q2 | Q4 | 69/155 |
| 2016 | IMMUNOLOGY | SCIE | Q2 | — | 64/151 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 83/151 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 85/148 |
| 2013 | IMMUNOLOGY | SCIE | Q2 | — | 58/144 |
| 2012 | IMMUNOLOGY | SCIE | Q3 | — | 69/137 |
| 2011 | IMMUNOLOGY | SCIE | Q3 | — | 103/139 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 129/134 |